Affiliation:
1. Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine Nagoya University Nagoya Japan
2. Department of Neuroscience and Pathobiology Nagoya University Graduate School of Medicine Nagoya Japan
3. Institute for Glyco‐core Research (iGCORE) Nagoya University Nagoya Japan
4. Center for One Medicine Innovative Translational Research (COMIT) Gifu University Institute for Advanced Study Gifu Japan
Abstract
AbstractNeuroinflammation, which is mediated by microglia, astrocytes, and infiltrated immune cells and leads to the subsequent production of proinflammatory molecules, is associated with the pathomechanism of Alzheimer's disease (AD). As the incidence of AD is higher in females than males, multiple studies have focused on the relationship between sex hormones and AD pathology. Androgen and estrogen receptors are expressed throughout the brain, including the hippocampus; thus, both sex hormones may regulate brain function, including cognitive function. Endogenous sex hormone levels are depleted by aging and cancer therapies, including prostate cancer and breast cancer therapies. Previous cohort studies have revealed that these conditions may also increase the risk of developing AD. Here we review previous findings from epidemiologic and preclinical studies on AD and provide an overview of the roles of sex hormones as risk factors of AD and regulators of AD pathology, including neuroinflammation. Furthermore, we discuss the therapeutic potential of sex hormone supplementation as a preventive or therapeutic treatment for AD based on the results of randomized control trials.
Funder
Japan Agency for Medical Research and Development
Japan Science and Technology Agency
Japan Society for the Promotion of Science
Japan Science and Technology Corporation
Takeda Science Foundation
Subject
Neurology (clinical),Immunology and Microbiology (miscellaneous),Immunology,Neuroscience (miscellaneous)
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献